Most versions of the multistage model predict that when persons stop smoking, their excess risk for lung cancer will continue to increase. Discussions of the model usually indicate that the excess risk stabilizes. The data show that the risk declines.
1 Current mathematical models for carcinogenesis1 imply that when persons stop smoking, their excess risk for lung cancer will continue to increase. Within the field of risk assessment, however, there seems to be general agreement that the excess risk stabilizes on cessation of exposure2-6 . We report here on data from three of the main cohort studies, and find that the excess risk declines; indeed, even the absolute risk (background + excess) seems to decline for about 20 years after cessation of smoking.
All the empirical studies we have identified, which correlate the risk in ex-smokers with time since quitting, confirm the finding that excess risk declines. We begin by reviewing the cohort studies. Hammond7 uses direct standardization on age, and concludes that after 10 years, the lung cancer risk for ex-smokers in the 25- The data quality is considered to be excellent; dose was ascertained on three separate questionnaires. Information on age at start of smoking, however, has not been published; following Doll & Peto, this value is imputed as 22.5 years (including some allowance for the time from malignancy to death). Although the study lasted 20 years with about 34,000 subjects, the number of events--lung cancer cases--is relatively small. There is some deficit in events at the highest ages, and at the highest dose. Dose is measured in cigarettes per day. Doll & Peto20 report data on non-smokers and current smokers, selecting only subjects who smoked at a nearly constant rate; only 215 events out of 571 are kept. The published data on ex-smokers are not in usable form, and the unpublished data do not appear to be available.
Summary data on ex-smokers, however, have been published21-23. The observed number will also be compared with the number expected for lifelong non-smokers of the same age.
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The multistage model is used as the basis for computing expected numbers. In effect, using the model trades variance for bias.
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Results
As shown in Table 1 for the veterans cohort, the crude risk of lung cancer among ex-smokers declines steadily from time of quitting.
- Table 1 were younger when they stopped smoking (although the differences are small).
----- Table 2 about here -----
The third column in Table 2 shows directly standardized risks; age is standardized as of the time when exposure stopped.
The standardized risk declines fairly steadily as a function of years since quit, except for a perhaps artifactual spike at 30-34
years.
----- Table 3 about here- Tables 3 and 4 repeat the analysis for the ACS cohort.
Crude risks are shown in Table 3 , and decline rapidly. Table 4 shows the standardized risks, and these still decline steadily, although not as rapidly.
----- Table 4 The figure is drawn in a logarithmic scale, so the risk 5 years afterward is about 50% of the risk at time of quitting.
- Table 5 - Column 3: The risk for persons aged 57 who never smoked.
Column 2: The risk equals for non-smokers as in column 3, plus the excess risk for the smokers as in column 1.
(Explicit formulas for the expecteds are in the Appendix.) Animal experiments also give some evidence; however, results depend on the test system. For skin painting, the risk drops after cessation of exposure3l-32 ; likewise, some liver lesions can be repaired33 . In the other direction, when dosing with 2-AAF stops, the risk of liver cancer continues to increase34 . The suggestion is that for some human carcinogens, excess risk will decline after cessation of exposure; for others, excess risk will stabilize or increase.
The quality of the data we use here must be considered. In Figure 1 Table 3 is reduced since the ACS volunteers were instructed to recruit only healthy subjects--and apparently succeeded, at least for the 9-state study8. The last line in Tables 1 and 2 may be low in part from the deficit in events among older persons. Other ad hoc arguments, however, would have to be invoked to explain away other lines in these tables.
The decline in crude risks for ex-smokers reported in Tables 1   and 3 cannot be explained by the multistage model: see column 2
of Table 5 and A more interesting idea is that the body can repair the lesions caused by smoking, and once the insult stops, the repair There are n stages, with the 1st and n-lst allowed to be sensitive. The dose is in cigarettes per day.
----- Table 7 In the ACS cohort, the data on non-smokers arrived after
we had fit the model on the current smokers using formula (2).
As a cross-validation test, we predicted the risk for the non-smokers using formula (1) . The prediction was 500 + 60 with 99 observed (P<1/1,000,000). The model cannot extrapolate from smokers to non-smokers even though there are a substantial number of events in the dose group 1-9 cigarettes per day.
Of course, lack of fit in Table 7 column 3 of Table 5 shows that this is not a good option.
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Using the model to compute expecteds
In Tables 5 and 6 , the E's for column 1 are obtained from equation (2), by setting current age t equal to age at quitting T1. The E's for column 2 are obtained by adding the term A(tn-1-T1n-i), which represents the increase in background risk from time of quitting (T1) to the present (t).
Column 3 is computed from equation (1); for the ACS cohort, A is re-estimated from the non-smokers only, as 1.8.
For the veterans, C=D=O, as shown in Table 7 ; and the multistage model does predict the freezing of excess risk. So column 2 in Table 5 in fact uses the E's from the multistage model, providing a direct test of the model. To illustrate the procedure for computing E's, column 1 in Table 8 shows risks per 100,000 person-years for a non-smoker at various ages t, computed from equation (1) . Column 2 shows the risks for a continuing smoker at the same ages, conmputed from equation (2); for this illustration, age at start is To=19 and the dose is d=30 cigarettes per day. Column 3 shows the risks for an ex-smoker, computed from equation (3); age at start is To=19, age at quit is Ti=42, and the dose was d=30 cigarettes per day.
- Table 8 around here -
A8
In column 1 of For the ACS cohort, C>0; so the E's underlying column 2 in Table 6 grow more slowly than the E's computed from equation (3): the E's for column 2 of Table 6 have excess risk frozen at quitting, while the E's from equation (3) incorporate increasing excess risk. A direct test of the model is provided in Table 8, which compares the O's with the E's from the model. Age at start was not ascertained for the ACS ex-smokers; we have imputed this several ways in Table 9 ; the value 19 years was the one used in Table 6 . In any case, the pattern of decline in O/E is not much affected by this choice.
----- 
